CSHP - California Society of Health-System Pharmacists

CSHP - California Society of Health-System Pharmacists Leaders in Wellness, Patient Safety and Optimal Use of Medications

Founded in 1962, the California Society of Health-System Pharmacists (CSHP) is a non-profit professional association established to serve the needs of hospital and health-system pharmacists. Representing over 4,500 members who practice clinical pharmacy and specialized medicine, CSHP is the largest state association for pharmacists. CSHP members share a common mission – to promote wellness, patient safety and the optimal use of medication.

FDA Approves First New Molecular Entity for Weight LossThe U.S. Food and Drug Administration (FDA) has approved the firs...
04/11/2026

FDA Approves First New Molecular Entity for Weight Loss

The U.S. Food and Drug Administration (FDA) has approved the first new molecular entity (NME) approved under the Commissioner's National Priority Voucher (CNPV) pilot program for weight loss. Foundayo (orforglipron) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. Foundayo (orforglipron) is administered as an oral tablet.

The safety and efficacy of Foundayo (orforglipron) was evaluated in a pool of two randomized, double-blind, placebo-controlled trials that included 3155 adult patients with obesity or overweight treated with FOUNDAYO once daily for up to 72 weeks and a 2-week off-drug follow-up period (Trial 1 and Trial 2).

Warnings and precautions for Foundayo (orforglipron) include a Boxed Warning for thyroid C-cell tumors. Foundayo (orforglipron) should not be used in patients with a personal or family history of medullary thyroid cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2. Other warnings and precautions for Foundayo (orforglipron) include pancreatitis, severe gastrointestinal reactions, acute kidney injury due to volume depletion, hypoglycemia, hypersensitivity, diabetic retinopathy in patients with type 2 diabetes mellitus, acute gallbladder disease, and pulmonary aspiration during general anesthesia or deep sedation. Foundayo (orforglipron) should not be used in combination with another GLP-1 receptor agonist.

The most common adverse reactions for Foundayo (orforglipron) include nausea, constipation, diarrhea, vomiting, dyspepsia, abdominal pain, headache, abdominal distension, fatigue, burping, gastroesophageal reflux disease, gas, and hair loss.

View the FDA’s announcement here:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program

04/10/2026

We’re speaking up for YOUR workplace flexibility! 📢💻

CSHP recently provided feedback to the Board of Pharmacy on the future of Remote Processing. Our goal? To make sure these rules support you, not bury you in paperwork.What we’re fighting for:

✅ Trusting Professionals: You shouldn't have to "designate" a specific room to do your job securely.

✅ Cutting Red Tape: We want to eliminate excessive record-keeping that makes it harder for pharmacists to work across multiple locations.

✅ Clarity for Hospitals: Ensuring institutional settings remain protected under existing laws.

Pharmacy is changing, and CSHP is making sure the regulations change with it.

Read our full letter at: https://bit.ly/4mfBl9i

National Prescription Drug is on Saturday, April 25, from 10 A.M. - 2 P.M. The Drug Enforcement Administration (DEA) N...
04/09/2026

National Prescription Drug is on Saturday, April 25, from 10 A.M. - 2 P.M.

The Drug Enforcement Administration (DEA) National Prescription Drug Take Back Day provides a safe, convenient, and anonymous means of disposing of prescription drugs at multiple locations throughout the country. is a free event for the public to properly dispose of old and unneeded medications safely and anonymously. Unused or expired medications are a public safety issue, and properly disposing of these unneeded medications saves lives and protects the environment.

Pharmacy practitioners play a key role in helping patients understand their drug expiration dates and when to safely dispose of expired or unused medications. Patients look to the pharmacy practitioners for all types of drug information - from possible side effects to administration guidance.

View the DEA’s Take Back Day Collection Site Locator here:
http://DEATakeBack.com/

The clock is ticking! ⏳ 3 Days to Go!We are officially in the final countdown for CSHP 2027 Leadership Nominations. This...
04/08/2026

The clock is ticking! ⏳ 3 Days to Go!

We are officially in the final countdown for CSHP 2027 Leadership Nominations. This is your chance to have a seat at the table and influence the strategic direction of health-system pharmacy in California.

We are seeking nominations for:

• President-Elect (1 position)
• Board of Directors (2 positions)
• ASHP Alternate Delegates (2 positions)

Don't wait until it’s too late—help us identify the visionaries who will lead us into 2027. 🚀

📅 Deadline: Friday, April 10th
🔗 Nominate at: https://bit.ly/4meMOWR

What a start to Pharmacy Policy & Legislative Day! 🏛️We kicked off our morning in Sacramento with an inspiring address f...
04/07/2026

What a start to Pharmacy Policy & Legislative Day! 🏛️

We kicked off our morning in Sacramento with an inspiring address from Assemblymember Heath Flora. It’s a privilege to have a leader who understands the challenges and triumphs of the pharmacy profession speaking to our members today.

Our advocates are officially briefed and ready to meet with legislators to discuss the future of healthcare in California. Stay tuned as we head to the North Ascent! 🚶‍♂️💼

CDC HAN: Medetomidine in the U.S. Illegal Fentanyl Supply Increasing Risk for Overdose and Severe Withdrawal Syndrome Th...
04/07/2026

CDC HAN: Medetomidine in the U.S. Illegal Fentanyl Supply Increasing Risk for Overdose and Severe Withdrawal Syndrome

The Centers for Disease Control and Prevention (CDC) has issued a Health Alert Network (HAN) Health Advisory, in conjunction with the White House Office of National Drug Control Policy (ONDCP), to notify public health professionals, clinicians, laboratorians, and people at risk for overdose about increasing reports from U.S. jurisdictions detecting medetomidine in the illegal drug supply and a severe withdrawal syndrome due to medetomidine exposure.

Medetomidine (also known as 'rhino tranq,' 'mede,' or 'dex') is not approved for human use but is approved for sedation and analgesia in dogs. Its dextro-isomer, dexmedetomidine, is approved for procedural sedation in humans. Medetomidine can cause profound sedation, bradycardia, and hypotension. Stopping medetomidine following regular use may lead to severe withdrawal with symptoms including hypertension, anxiety, nausea, vomiting, and fluctuating alertness, which can require emergency or intensive care. In most overdose cases involving medetomidine, fentanyl is also involved, and opioid overdose reversal medications (OORM), such as naloxone, should be administered to restore normal breathing in suspected overdoses.

The CDC recommends clinicians consider medetomidine in suspected opioid overdoses with prolonged sedation unresponsive to OORM administration, consult a toxicologist or poison control at 1-800-222-1222, and report unusual cases to the appropriate health department.

View the CDC’s HAN Health Advisory here:
https://www.cdc.gov/han/php/notices/han00527.html

Our advocacy family is growing! 🏛️💊 A huge shoutout to our latest Chapter Sponsors for Pharmacy Policy & Legislative Day...
04/06/2026

Our advocacy family is growing! 🏛️💊 A huge shoutout to our latest Chapter Sponsors for Pharmacy Policy & Legislative Day 2026:

🌲 Diablo
🏔️ Inland

They’re joining our mission to ensure pharmacy's voice is heard loud and clear at the Capitol. We can’t wait to see everyone in Sacramento tomorrow, April 7th! 📢✨

Stronger Together: A Huge Thank You to Our Chapter Sponsors! 🏛️💊Advocacy starts at the local level, and we are incredibl...
04/05/2026

Stronger Together: A Huge Thank You to Our Chapter Sponsors! 🏛️💊

Advocacy starts at the local level, and we are incredibly grateful to our CSHP Chapters for their support of Pharmacy Policy & Legislative Day 2026.

Because of these chapters, our members from across California can come together in Sacramento to make our collective voice heard. Thank you for leading the way in your communities and at the Capitol!

A special thank you to:
🍊 Orange County
🌾 Sacramento Valley
☀️ San Diego
🏔️ San Gabriel Valley
⛵ South Bay Long Beach

See you all in Sacramento on April 7th!

"Don’t wait until you feel completely ready." 💬✨That is the simple yet powerful advice from our latest Member Spotlight,...
04/05/2026

"Don’t wait until you feel completely ready." 💬✨

That is the simple yet powerful advice from our latest Member Spotlight, Michelle Rose! From her early days as a UCSF student organizing health fairs to meeting with U.S. Congresswoman Judy Chu, Michelle’s career is proof of what happens when you raise your hand and say "yes" to the opportunity. 🙋‍♀️🏢

Why Michelle inspires us:
🏆 She’s a Platinum Advocacy Champion fighting for AB 2571.
🤝 She’s a dedicated mentor to the next generation of pharmacy stars.
❤️ She’s driven by a deep love for her patients.

Read the full spotlight at: https://bit.ly/4v0yu89

FDA Approves First Treatment for Cerebral Folate Transport DeficiencyThe U.S. Food and Drug Administration (FDA) has app...
04/04/2026

FDA Approves First Treatment for Cerebral Folate Transport Deficiency

The U.S. Food and Drug Administration (FDA) has approved the first treatment for cerebral folate deficiency in adult and pediatric patients who have a confirmed variant in the folate receptor 1 gene (CFD-FOLR1). Wellcovorin (leucovorin calcium) is a folate analog administered as an oral tablet. The FDA approved the expanded use of Wellcovorin (leucovorin calcium) to treat cerebral folate transport deficiency, which is a rare genetic disease.

Warning and precautions for leucovorin include anaphylaxis. If this occurs, leucovorin should be withheld or permanently discontinued and requires immediate medical attention. The most common adverse reactions for leucovorin include pruritus, rash, urticaria, dyspnea, rigors, and impaired thermoregulation.

View the FDA’s announcement here:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-cerebral-folate-transport-deficiency

04/03/2026

Advocacy is at the core of everything we do at CSHP. 📢

Watch as CSHP member & representative, Dr. Andre Pieterse, shares his perspective as both a pharmacist and a rural resident on the importance of AB 1671.

This bill isn't just about grants; it's about supporting the providers who are on the ground delivering life-saving care every single day.

💪 Let’s bridge the gap in healthcare access together!

Empowering the Next Generation of Advocates 🎓✨A massive thank you to the UCSF School of Pharmacy for sponsoring this yea...
04/03/2026

Empowering the Next Generation of Advocates 🎓✨

A massive thank you to the UCSF School of Pharmacy for sponsoring this year’s Pharmacy Policy & Legislative Day!

Investing in advocacy means investing in the future of our profession. We are honored to have the support of such a prestigious institution as we prepare to engage with lawmakers and shape the practice landscape in California. 🏛️

Thank you, UCSF, for helping us provide a platform for students and professionals alike to champion the role of the pharmacist.

Address

1314 H Street, Ste 100
Sacramento, CA
95814

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+19164471033

Website

Alerts

Be the first to know and let us send you an email when CSHP - California Society of Health-System Pharmacists posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CSHP - California Society of Health-System Pharmacists:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category